New paper (bit.ly/3TdtbS5) in @AdvSciNews (Advanced Materials) describes novel biomaterial scaffold, the “artificial lymph node matrix,” to stimulate production of antigen-specific T immune cells. Natalie K. Livingston Johns Hopkins Medicine Johns Hopkins Pathology Johns Hopkins BME Johns Hopkins MatSci Translational Tissue Engineering Center

Leveraging antibody profiling for advanced healthcare insights lifesciencesintelligence.com/features/lever…

A fantastic collaboration with @thesteinegger and very excited about future projects using this type of approach to discover novel peptide therapeutics. If you have ideas for applications or indications, please reach out to us!

Taking Pharokka output as input, Phold uses the ProstT5 protein language model to rapidly convert amino acid sequences to Foldseek 3Di structural tokens, & then searches these with Foldseek against a database of 1M+ phage protein structures folded with Colabfold (2/n)

Calling local biomedical professionals! Please attend our open house to learn how your cohort study can benefit from antibody reactome profiling. You'll get to see our beautiful Baltimore lab and can enter to win a new Apple Vision Pro 🤯 Please RT to help spread the word!

Eric Topol Absolutely agree with Eric Topol ! 🙌 Characterizing the "immunome"—from lifetime viral exposures to autoantibody reactivities—provides critical insights into disease mechanisms and biomarker development. We are the leader in comprehensive antibody reactome profiling, and are

Last week, we hosted students and faculty from Coppin Academy High School. It was inspiring to see Baltimore's best and brightest experience hands-on STEM experiments and immunology learnings- the future looks bright! 💫 #STEM #Baltimore #Immunology #Reactome

🎉 Congratulations to Kate Grabowski , PhD (Associate Professor of Pathology, Johns Hopkins School of Medicine Faculty) for winning the Apple Vision Pro raffle at our Open House! 🥳 Thank you to everyone who joined us to explore our innovative MIPSA technology and antibody

𝗖𝗼𝗵𝗼𝗿𝘁 𝘀𝘁𝘂𝗱𝘆 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗲𝗲𝗸 - The article “𝘋𝘪𝘴𝘦𝘢𝘴𝘦 𝘥𝘪𝘢𝘨𝘯𝘰𝘴𝘵𝘪𝘤𝘴 𝘶𝘴𝘪𝘯𝘨 𝘮𝘢𝘤𝘩𝘪𝘯𝘦 𝘭𝘦𝘢𝘳𝘯𝘪𝘯𝘨 𝘰𝘧 𝘉 𝘤𝘦𝘭𝘭 𝘢𝘯𝘥 𝘛 𝘤𝘦𝘭𝘭 𝘳𝘦𝘤𝘦𝘱𝘵𝘰𝘳 𝘴𝘦𝘲𝘶𝘦𝘯𝘤𝘦𝘴” published in Science Magazine from corresponding authors Anshul

We are thrilled to announce that Infinity Bio has closed our Series A investment, led by the amazing team at Illumina Ventures. As part of the deal, Infinity Bio has acquired Serimmune Inc, a complementary antibody reactome service provider. This event marks a major milestone